ESCEO
@esceo.org
The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a not-for-profit organization, dedicated to a close interaction between clinical scientists dealing with bone, joint and muscle disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of Osteoporosis, Osteoarthritis and Sarcopenia within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception.
ESCEO's Company Logos
ESCEO's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#1658A5
Fun Blue
22, 88, 165
212, 76, 37
87, 47, 0, 35
#D6A475
Whiskey
214, 164, 117
29, 54, 65
0, 23, 45, 16
#002C47
Prussian Blue
0, 44, 71
203, 100, 14
100, 38, 0, 72
About ESCEO
The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a not-for-profit organization dedicated to bringing together clinical scientists, pharmaceutical industry professionals, regulators, and health policymakers to effectively manage and treat bone, joint, and muscle disorders. ESCEO aims to integrate the management of Osteoporosis, Osteoarthritis, and Sarcopenia within the comprehensive perspective of health resources utilization.
ESCEO provides the latest news, publications, and events related to advancements in the field. They offer systematic reviews, meta-analyses, and studies on topics such as the efficacy of osteoporosis pharmacological treatments in men and the instrumental evaluation of gait smoothness and history of falling in older persons.
Additionally, ESCEO publishes the official journal "Aging Clinical and Experimental Research," which covers various aspects of gerontology and geriatrics. They also endorse SarQoL, the only validated questionnaire for assessing the quality of life in sarcopenic patients.
Company type
Nonprofit
Year founded
2005
Company size
2-10 employees
